ICON plc (NASDAQ:ICLR) traded sharply lower on Thursday, sparking a selloff among its rival contract research organizations after the Ireland-based company cut its guidance with its Q3 results. In ...

Clinical research organization ICON plc (NASDAQ:ICLR) announced its financial guidance for fiscal year 2025 on Tuesday. What Happened: The Dublin-based company forecasts revenues of $8.05 billion — $8 ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Icon ( (ICLR)) just unveiled an update.

The DCF model suggests that ICON is undervalued by 98.23%. Between 2018 and 2024, the company's revenues increased by 219.04% and by 145.30%, respectively. This year, ICLR will implement a program to ...

ICON plc ICLR is well-poised to grow in the upcoming quarters, driven by its strategic additions. Leveraging AI and technology advancements, the company is optimizing clinical delivery and has seen ...

The consolidation brings together two organizations with a history of robust growth and performance ready to build on this strength using the outstanding talent of both companies to deliver enhanced ...

ICON has agreed to acquire PRA Health Sciences for approximately $12 billion in cash and stock, the companies said, in a deal that continues the consolidation of contract research organizations (CROs) ...

Short interest in Icon PLC (NASDAQ:ICLR) increased during the last reporting period, rising from 1.89M to 1.90M. This put 2.5% of the company's publicly available shares short. Based on the recent ...

An announcement from Icon Energy Corp. ( ($ICON) ) is now available. In December 2025, Icon Energy Corp. reported a strengthened commercial ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...